Company / Cash & Equivalents
VIEMED HEALTHCARE, INC. Cash & Equivalents History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$13.5M
FY2025
5-year range
$12.8M / $28.4M
FY2021-FY2025
Trend
-23.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 7 years, ranging from $13M in FY2023 to $31M in FY2020.
Based on SEC 10-K filings.
$14M in FY2025 with a 5-year CAGR of -15.3%.
Improved from $13M to $14M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -7.2%
- 5-Year CAGR
- -15.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.3%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 23.0% year-over-year.
- Peak cash & equivalents was recorded in FY2020.
- Lowest cash & equivalents in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.5M | -23.0% |
| FY2024 | $17.5M | +36.6% |
| FY2023 | $12.8M | -24.1% |
| FY2022 | $16.9M | -40.5% |
| FY2021 | $28.4M | -8.3% |
| FY2020 | $31.0M | +132.0% |
| FY2019 | $13.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026